Candidase
This fact-check may be outdated. Consider refreshing it to get the most current information.
Executive summary
Candidase is an over‑the‑counter enzyme supplement from Enzymedica marketed to support intestinal “yeast” balance by combining cellulase and protease to break down fungal cell walls and proteins [1]. Sales pages and retailers emphasize digestive and microbiome benefits but include the standard disclaimer that the product’s claims have not been evaluated by the FDA [2].
1. What Candidase is and how the maker says it works
Enzymedica describes Candidase as a targeted enzyme blend—primarily cellulase to digest cellulose in yeast cell walls and protease to break down internal proteins—sold to promote a “gentle, cleansing” effect and balanced intestinal flora, sometimes packaged as a standard or extra‑strength formula with dosing recommendations for moderate or acute symptoms [1] [3].
2. Claims, marketing and regulatory context
Retailers and product pages consistently repeat Enzymedica’s positioning that Candidase helps maintain healthy Candida levels and supports the microbiome, with claims that enzymes act like “scissors” to cut apart yeast [1] [4]. At the same time, product listings and reseller notes warn that statements have not been evaluated by the FDA and that supplements are not meant to diagnose, treat, cure or prevent disease, a disclosure that appears on multiple vendor pages [2] [5].
3. User experience: what customers report
Customer reviews collected across iHerb, Walmart, Vitacost and other sellers show a mix of outcomes: many users report reduced bloating, clearer skin and improved digestion after taking Candidase or its extra‑strength variant [6] [7] [8]. Several reviewers also describe transient adverse effects consistent with an expected “die‑off” or digestive response—bloating, gas, fatigue, diarrhea and in a few accounts a noticeable white film in stool—sometimes resolving after a few days [5] [9] [6].
4. Safety notes and drug interactions mentioned by sellers
Vendor pages and product information admonish users not to take Candidase with timed‑release medications that use cellulose as a release mechanism because its cellulase activity could affect those formulations, and they advise consulting a physician for pregnancy, serious medical conditions, or concurrent medications; such caveats are part of the product labeling on retailer sites [10] [2].
5. Scientific evidence and gaps in reporting
The available reporting in this dataset is overwhelmingly manufacturer content and customer testimonials; there are no clinical trials, third‑party clinical summaries or peer‑reviewed studies cited in these sources to substantiate the magnitude of the product’s effects or to quantify risks, meaning efficacy and safety beyond anecdote remain unverified in the provided material [1] [8] [2]. The materials do reference a physiological rationale—enzymes breaking down components of yeast—but offer no independent clinical data within these pages [1].
6. Practical takeaways and reasonable skepticism
For people considering Candidase the record in these sources suggests potential symptomatic benefit for some users (less bloating, clearer skin) and a plausible biochemical mechanism via cellulase/protease activity [8] [1], but readers should weigh this against inconsistent outcomes, reported short‑term digestive reactions that some interpret as “die‑off,” and the lack of FDA evaluation or cited clinical trials in the provided reporting [9] [2]. Retail warnings about interactions with cellulose‑based time‑release drugs and the standard supplement disclaimers indicate the product should be treated as a supplement—not a medically proven antifungal therapy—and that clinicians should be consulted for people on medications or with medical conditions [10] [2].